- Home
- CLSD vs INO Comparison
CLSD vs INO Comparison
Compare CLSD & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLSD
- INO
- Stock Information
- Founded
- CLSD 2011
- INO 1979
- Country
- CLSD United States
- INO United States
- Employees
- CLSD N/A
- INO N/A
- Industry
- CLSD Biotechnology: Pharmaceutical Preparations
- INO Medical/Dental Instruments
- Sector
- CLSD Health Care
- INO Health Care
- Exchange
- CLSD Nasdaq
- INO Nasdaq
- Market Cap
- CLSD 68.4M
- INO 69.3M
- IPO Year
- CLSD 2016
- INO 1998
- Fundamental
- Price
- CLSD $0.46
- INO $1.43
- Analyst Decision
- CLSD Hold
- INO Buy
- Analyst Count
- CLSD 4
- INO 5
- Target Price
- CLSD $4.33
- INO $8.80
- AVG Volume (30 Days)
- CLSD 12.7M
- INO 3.3M
- Earning Date
- CLSD 08-11-2025
- INO 08-07-2025
- Dividend Yield
- CLSD N/A
- INO N/A
- EPS Growth
- CLSD N/A
- INO N/A
- EPS
- CLSD N/A
- INO N/A
- Revenue
- CLSD $3,764,000.00
- INO $283,099.00
- Revenue This Year
- CLSD $143.33
- INO N/A
- Revenue Next Year
- CLSD N/A
- INO $20,588.06
- P/E Ratio
- CLSD N/A
- INO N/A
- Revenue Growth
- CLSD N/A
- INO N/A
- 52 Week Low
- CLSD $0.29
- INO $1.30
- 52 Week High
- CLSD $1.65
- INO $11.44
- Technical
- Relative Strength Index (RSI)
- CLSD 34.58
- INO 41.94
- Support Level
- CLSD $0.29
- INO $1.46
- Resistance Level
- CLSD $0.62
- INO $1.56
- Average True Range (ATR)
- CLSD 0.11
- INO 0.07
- MACD
- CLSD -0.02
- INO 0.03
- Stochastic Oscillator
- CLSD 25.16
- INO 55.00
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.